Methods for identifying and isolating tissue-specific lumen-exposed molecules
CA 2409333 A1 · Owner: Utah Ventures Ii, L.P. · Inventors: Stevens, Anthony C.; Roben, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides novel methods of and kits for labeling and isolating lumen-exposed molecules, particularly polypeptides which are expressed in a tissue-specific or organ-specific manner. The methods and kits can be used to isolate molecules exposed on the luminal side of cells lining vascular ductal, sinus, respiratory, fascial, and other perfusible tissue spaces.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.